MedPath

Clinical efficacy and safety of Isha Balm

Not Applicable
Not yet recruiting
Conditions
Headache
Registration Number
CTRI/2018/02/011819
Lead Sponsor
Isha Arogya pvt ltd
Brief Summary

This study a single arm study among the outpatient attending the clinic. To study the safety and therapeutic efficacy of indigenous herbal formulation of Isha Arogya namely Isha Balm  topical application used as a supportive theraphy among patients presenting with headache and nasal symptoms. 30 patients for the period of 15 days.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

1Patients attending the clinic in the age group of 12 years and above and both the sexes included 2 Patients provisionally diagnosed to have viral prodrome, common cold, acute sinusitis, tension headache, migraine headache with the symptom of headache are included the study with their consent.

Exclusion Criteria
  • 1 past medical records needing neurological evaluation for headache 2known cases of hypertention, and those getting treatment complications of uncontrolled hypertention 3having ophthalmic complaints 4Patients with serious co-morbid illnesses such as known cardiac vascular disease, cancer induced pain, injuries due to fall or accidents, systemic illness like SLE,etc •Patients below the age of 12 years and above 60 years.
  • •Patients who are not willing to give informed written consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief from headache3 days
Secondary Outcome Measures
NameTimeMethod
Relief from Nasal block3 days

Trial Locations

Locations (1)

Isha Arogya Health Centre chennai

🇮🇳

Chennai, TAMIL NADU, India

Isha Arogya Health Centre chennai
🇮🇳Chennai, TAMIL NADU, India
Dr S Keerthiga
Principal investigator
9442590085
keerthiga.black@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.